Security Snapshot

AYTU BIOPHARMA, INC - Common Stock (AYTU) Institutional Ownership

CUSIP: 054754858

13F Institutional Holders and Ownership History from Q1 2023 to Q2 2026

Latest Period

Q1 2026

Institutions Reporting

34

Shares (Excl. Options)

3,903,172

Price

$2.73

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
AYTU on Nasdaq
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
3,903,172
Latest holder snapshot 5 signals
Total 13F value
$10,653,381
Portfolio coverage rank
0%
Share change
+122,148
Value change
+$348,828
Number of holders
34
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
10,724,234
SEC-reported price per share
$2.25
Insider filing price
$2.25
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • AYTU - AYTU BIOPHARMA, INC - Common Stock is tracked under CUSIP 054754858.
  • 34 institutions reported positions in Q1 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 34 to 9 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $10,653,381 to $636,838.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 34 institutions filings for Q1 2026.

Open SEC evidence

Security key

054754858

Latest holder period

Q1 2026

13F holders

34

13D/G owners

3

CIK / CUSIP context first

Open Q1 2026 holders AYTU full holder history AYTU BIOPHARMA, INC SEC filings AYTU BIOPHARMA, INC company facts AYTU BIOPHARMA, INC insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
AYTU
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 14% $1,423,724 1,086,812 Nantahala Capital Management, LLC 06 Jun 2025
LYTTON LAURENCE W 10% 0% $2,828,367 -$40,051 1,071,351 -1.4% LYTTON LAURENCE W 31 Dec 2025
Stonepine Capital Management, LLC 9.9% $1,975,217 906,063 Stonepine Capital Management, LLC 30 Jun 2025

As of 31 Mar 2026, 34 institutional investors reported holding 3,903,172 shares of AYTU BIOPHARMA, INC - Common Stock (AYTU). This represents 36% of the company’s total 10,724,234 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
36%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 10% 1,086,812 0% 0.19% $2,966,997
Stonepine Capital Management, LLC 7.4% 792,289 -2.6% 1.9% $2,162,949
AWM Investment Company, Inc. 5.8% 619,574 0% 0.19% $1,691,437
DIADEMA PARTNERS LP 3.3% 353,077 +15% 0.43% $963,900
VANGUARD CAPITAL MANAGEMENT LLC 2.4% 261,146 0% 0% $712,929
CROWN ADVISORS MANAGEMENT, INC. 1.4% 145,000 0.26% $395,000
TWO SIGMA INVESTMENTS, LP 1.1% 121,973 +14% 0% $332,986
RENAISSANCE TECHNOLOGIES LLC 0.87% 93,723 +4.6% 0% $255,864
Persistent Asset Partners Ltd 0.87% 92,897 +17% 0.1% $253,609
GEODE CAPITAL MANAGEMENT, LLC 0.86% 92,636 +25% 0% $252,933
VANGUARD FIDUCIARY TRUST CO 0.44% 47,048 0% 0% $128,441
DIMENSIONAL FUND ADVISORS LP 0.41% 43,585 +23% 0% $118,987
CITADEL ADVISORS LLC 0.34% 36,841 +137% 0% $100,576
BELLEVUE ASSET MANAGEMENT, LLC 0.23% 25,013 0% 0.03% $68,285
BlackRock, Inc. 0.21% 22,793 0% 0% $62,225
XTX Topco Ltd 0.2% 21,582 -17% 0% $58,919
NORTHERN TRUST CORP 0.18% 19,169 0% 0% $52,331
ACADIAN ASSET MANAGEMENT LLC 0.1% 10,237 0% 0% $27,000
Daytona Street Capital LLC 0.09% 10,000 0% 0.02% $26,800
MAI Capital Management 0.03% 3,575 0% 0% $9,760
UBS Group AG 0.02% 1,663 -45% 0% $4,539
Tower Research Capital LLC (TRC) 0.01% 1,564 -8.7% 0% $4,270
OSAIC HOLDINGS, INC. 0% 462 +0.43% 0% $1,259
JPMORGAN CHASE & CO 0% 154 0% $405
WELLS FARGO & COMPANY/MN 0% 127 0% 0% $347

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
14
Latest
Q1 2026
Rows shown
1-14 of 14
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 295,808 $636,838 +$193 $2.15 9
2026 Q1 3,903,172 $10,653,381 +$348,828 $2.73 34
2025 Q4 3,771,496 $9,805,147 +$483,628 $2.60 37
2025 Q3 3,580,253 $6,730,606 +$120,541 $1.88 31
2025 Q2 3,416,181 $7,446,105 +$3,456,447 $2.18 30
2025 Q1 1,876,606 $2,489,917 +$8,023 $1.20 29
2024 Q4 1,880,741 $3,193,340 -$294,695 $1.70 28
2024 Q3 2,048,299 $4,813,170 -$27,368 $2.35 23
2024 Q2 2,053,775 $5,994,953 +$752,481 $2.92 26
2024 Q1 1,795,464 $5,457,735 +$79,751 $3.04 26
2023 Q4 1,769,256 $5,024,294 +$125,688 $2.84 21
2023 Q3 1,724,718 $4,655,967 +$78,103 $2.70 20
2023 Q2 1,704,120 $2,726,370 +$1,773,284 $1.60 19
2023 Q1 540,753 $1,211,630 +$1,211,205 $2.24 18
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .